MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 04-22-2025
Danaher Corporation Shares 2011-2025 | DHR
Annual Shares Danaher Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 731 M | 736 M | 725 M | 715 M | 706 M | 715 M | 701 M | 696 M | 691 M | 698 M | 702 M | 696 M | 693 M | 676 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 736 M | 676 M | 706 M |
Quarterly Shares Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 716 M | 719 M | 741 M | - | - | 727 M | 716 M | 715 M | 715 M | 714 M | 713 M | 711 M | 711 M | 705 M | 697 M | 696 M | 719 M | 718 M | 708 M | 702 M | 701 M | 700 M | 699 M | 697 M | 696 M | 695 M | 694 M | 692 M | 692 M | 691 M | 689 M | 687 M | 688 M | 710 M | 707 M | 704 M | 703 M | 701 M | 700 M | 698 M | 698 M | 695 M | 692 M | 688 M | 695 M | 696 M | 692 M | 688 M | 687 M | 667 M | 662 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 741 M | 662 M | 701 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M |  USA |
 |
Brainsway Ltd.
BWAY
|
31.2 M | $ 19.29 | -1.73 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 40.09 | -0.27 % | $ 1.11 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 21.26 | -2.34 % | $ 229 M |  China |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
DarioHealth Corp.
DRIO
|
28.4 M | $ 10.04 | -0.99 % | $ 285 M | Israel |
 |
DexCom
DXCM
|
386 M | $ 67.42 | 0.84 % | $ 26 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
BioNano Genomics
BNGO
|
1.27 M | $ 1.52 | -0.65 % | $ 1.93 M | USA |
 |
Exact Sciences Corporation
EXAS
|
185 M | $ 101.54 | -0.05 % | $ 18.8 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 27.01 | -0.55 % | $ 817 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
53.8 M | $ 19.73 | -1.45 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
39.4 M | $ 102.61 | 0.25 % | $ 4.05 B | USA |
 |
Anixa Biosciences
ANIX
|
31.9 K | $ 3.42 | 3.64 % | $ 109 K | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 0.24 | -1.79 % | $ 7.04 M | USA |
 |
IQVIA Holdings
IQV
|
181 M | $ 226.02 | 0.39 % | $ 41 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Guardant Health
GH
|
123 M | $ 102.38 | -0.12 % | $ 12.6 B | USA |
 |
NeoGenomics
NEO
|
127 M | $ 12.3 | -0.97 % | $ 1.56 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 7.14 | -0.14 % | $ 1.55 B | USA |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | USA |
 |
National Research Corporation
NRC
|
24.5 M | $ 18.81 | -1.05 % | $ 462 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Organovo Holdings
ONVO
|
1.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 M | - | -16.95 % | $ 1.54 M | USA |
 |
OPKO Health
OPK
|
694 M | $ 1.3 | -0.76 % | $ 902 M | USA |
 |
Mettler-Toledo International
MTD
|
21.2 M | $ 1 417.16 | 0.18 % | $ 30.1 B |  Schweiz |
 |
Illumina
ILMN
|
159 M | $ 135.32 | -0.64 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
51.4 M | $ 203.16 | 0.14 % | $ 10.4 B | USA |
 |
ENDRA Life Sciences
NDRA
|
537 K | $ 5.1 | - | $ 2.74 M | USA |
 |
Pacific Biosciences of California
PACB
|
254 M | $ 1.88 | 3.3 % | $ 477 M | USA |
 |
PerkinElmer
PKI
|
123 M | - | -0.91 % | $ 14.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 175.92 | 0.48 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
130 M | $ 6.82 | 1.04 % | $ 884 M | USA |
 |
Myriad Genetics
MYGN
|
90.6 M | $ 6.55 | -0.15 % | $ 593 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.9 M | $ 254.46 | 0.52 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 183.68 | 0.33 % | $ 15.2 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
82.5 M | $ 688.18 | 0.86 % | $ 56.8 B | USA |